showed that targeting Ang-2 with miRNA-542-3p reduced tumor growth, angiogenesis, and metastasis in animal models (He et al., 2014)
At Perfect B in Doral, all peptide protocols begin with an APRN intake evaluation
Published in Pharmaceuticals (PMID: 38675421), this 41-page open-access review proposes that BPC-157, while not meeting classical neurotransmitter criteria, functions as a cytoprotection mediator with neurotransmitter-like activity through a network of interconnected evidence. What Makes BPC-157 Unique BPC-157 is a 15-amino acid peptide (sequence: GEPPPGKPADDAGLV, molecular weight 1419) native and stable in human gastric juice for over 24 hours, showing no sequence homology with known gut peptides
For example, it is effective for healing lesions from excessive NSAIDs or alcohol.[ref][ref] Another study found that BPC 157 counteracted stomach and liver lesions and various encephalopathies in NSAIDs and insulin rats. [ref] BPC-157 completely resolved symptoms after major intestinal surgery in rats
Also, both the aforementioned products are not FDA approved for human-use, and only limited to research environments